TGTX

Tg Therapeutics Inc Earnings

$30.97

Earnings Summary

Revenue	$161.71Mn
Net Profits	$390.9Mn
Net Profit Margins	241.73%

Highlights

Revenue:

Tg Therapeutics Inc’s revenue jumped 92.79% since last year same period to $161.71Mn in the Q3 2025. On a quarterly growth basis, Tg Therapeutics Inc has generated 14.57% jump in its revenue since last 3-months.

Net Profits:

Tg Therapeutics Inc’s net profit jumped 9974.61% since last year same period to $390.9Mn in the Q3 2025. On a quarterly growth basis, Tg Therapeutics Inc has generated 1286.79% jump in its net profits since last 3-months.

Net Profit Margins:

Tg Therapeutics Inc’s net profit margin jumped 5125.74% since last year same period to 241.73% in the Q3 2025. On a quarterly growth basis, Tg Therapeutics Inc has generated 1110.46% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Tg Therapeutics Inc post its latest quarter earnings

EPS Estimate Current Quarter	0.33
EPS Estimate Current Year	0.33

Highlights

EPS Estimate Current Quarter:

Tg Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.33 - a 48.68% jump from last quarter’s estimates.

EPS Estimate Current Year:

Tg Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.33.

Key Ratios

Key ratios of the Tg Therapeutics Inc post its Q4 2025 earnings

Earning Per Share (EPS)

Highlights

Earning Per Share (EPS):

Tg Therapeutics Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q4 2025. This indicates that the Tg Therapeutics Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.